Connecticut
November 8, 2023: Development Strategy for Preclinical to Clinical Success
Alexia Kedves, Sr Director, CSO Partner Team, Curie.Bio
Catherine Mesner, Advisor, Danforth Advisors
Jennifer Good, President & CEO, Trevi Therapeutics
Paul Miller, CSO, Artizan Biosciences
Moderated by Ramani Varanasi, Managing Director, Danforth Advisors
April 19, 2023: The Role of Executive Leadership in Building Innovation-Focused Cultures
Kat Kaiser-Bricker, CSO, Halda Therapeutics
Ranjit Bindra, CEO, Modifi Bio
Rob Berman, Co-founder, Biohaven Pharmaceuticals & Adjunct Prof of Psychiatry, Yale
Moderated by John Hallinan, CDO, Danforth Advisors
October 12, 2022: Alternative Forms of Financing
Jenn Beecham, Associate Director, Blavatnik Fund
Mary Anne Rooke, Managing Director, Angel Investor Forum
Michael Invernale, Sr Licensing Manager, UCONN & Consultant, CTNext
Randy Teel, Corporate Strategy & Bus Dev, Arvinas
Moderated by Gregg Beloff, Managing Director, Danforth Advisors
May 11, 2022: Challenges of Being a Public Company
David Wurzer, Venture Partner, Connecticut Innovations
Erika Smith, CEO, ReNetX Bio
Lisa Delfini, CFO, Trevi Therapeutics
Moderated by Gregg Beloff, Managing Director, Danforth Advisors